BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25161269)

  • 21. Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation.
    Malki MMA; Gendzekhadze K; Stiller T; Mokhtari S; Karanes C; Parker P; Snyder D; Forman SJ; Nakamura R; Nademanee A
    Bone Marrow Transplant; 2020 Feb; 55(2):409-418. PubMed ID: 31551519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
    Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
    Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors.
    Burt C; Parker A; McQuaker G; Copland M; Brierley C; Little AM; Clark A
    Bone Marrow Transplant; 2014 May; 49(5):657-63. PubMed ID: 24535129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA-DPB1 typing.
    Stenger W; Künkele A; Niemann M; Todorova K; Pruß A; Schulte JH; Eggert A; Oevermann L
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28127. PubMed ID: 31850671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
    Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
    J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
    Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
    Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
    Varney MD; Lester S; McCluskey J; Gao X; Tait BD
    Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
    Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H; Yong A; Gandhi M; Dandoy C; Savani B; Hale G; Page K; Bitan M; Reshef R; Drobyski W; Marsh SG; Schultz K; Müller CR; Fernandez-Viña MA; Verneris MR; Horowitz MM; Arora M; Weisdorf DJ; Lee SJ
    Haematologica; 2016 Oct; 101(10):1267-1274. PubMed ID: 27247320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
    Shaw BE; Gooley TA; Malkki M; Madrigal JA; Begovich AB; Horowitz MM; Gratwohl A; Ringdén O; Marsh SG; Petersdorf EW
    Blood; 2007 Dec; 110(13):4560-6. PubMed ID: 17726164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant.
    Solomon SR; Aubrey MT; Bachier-Rodriguez L; Solh MM; Jackson KC; Zhang X; Roark CL; Holland HK; Morris LE; Bashey A
    Transplant Cell Ther; 2024 Jun; 30(6):608.e1-608.e10. PubMed ID: 38561140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
    Thus KA; Ruizendaal MT; de Hoop TA; Borst E; van Deutekom HW; Te Boome L; Kuball J; Spierings E
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1705-10. PubMed ID: 24980111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
    Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
    Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
    Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
    Koh H; Nakamae H; Hagihara K; Nakane T; Manabe M; Hayashi Y; Nishimoto M; Umemoto Y; Nakamae M; Hirose A; Inoue E; Inoue A; Yoshida M; Bingo M; Okamura H; Aimoto R; Aimoto M; Terada Y; Koh KR; Yamane T; Ohsawa M; Hino M
    J Exp Clin Cancer Res; 2011 Apr; 30(1):36. PubMed ID: 21477348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
    Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.
    Crivello P; Heinold A; Rebmann V; Ottinger HD; Horn PA; Beelen DW; Fleischhauer K
    Blood; 2016 Jul; 128(1):120-9. PubMed ID: 27162243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
    Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.
    Kanda J; Saji H; Fukuda T; Kobayashi T; Miyamura K; Eto T; Kurokawa M; Kanamori H; Mori T; Hidaka M; Iwato K; Yoshida T; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Kanda Y
    Blood; 2012 Mar; 119(10):2409-16. PubMed ID: 22042692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.
    Morishima S; Shiina T; Suzuki S; Ogawa S; Sato-Otsubo A; Kashiwase K; Azuma F; Yabe T; Satake M; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Blood; 2018 Feb; 131(7):808-817. PubMed ID: 29246901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.